Rovi gets enoxaparin in Spain and France

Laboratorios Farmacéuticos Rovi has expanded the presence of its enoxaparin in Europe, after launching a rival to Sanofi’s Lovenox under its own name in Spain and introducing its Crusia version in France via a partnership with Biogaran.